Trials / Completed
CompletedNCT00248456
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris
A Randomised, Double-blind, Active-controlled, Parallel, Multi-center Study to Investigate the Efficacy and Safety of Daivobet® Ointment in Patients With Psoriasis Vulgaris
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 320 (planned)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy and safety of calcipotriol plus betamethasone dipropionate ointment compared with calcipotriol ointment in the treatment of patients with psoriasis vulgaris for a duration of 4 weeks. The study will focus on the percentage change of the psoriasis area and severity index (PASI) from baseline to the end of week 4.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcipotriol plus betamethasone dipropionate ointment |
Timeline
- Start date
- 2005-10-01
- Completion
- 2006-02-01
- First posted
- 2005-11-04
- Last updated
- 2025-02-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00248456. Inclusion in this directory is not an endorsement.